N/A
N=27
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
Onychomycosis
Bottom Line
View on ClinicalTrials.gov: NCT01666002 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
May 2016
Primary outcome: Primary: The Primary End Point Was the Percentage of Patients With a Negative Mycological Culture. — 12; 10 percentage of participants — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Laser Treatment (Pulsed Nd:YAG 1064 nm Laser) (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Oct 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Primary End Point Was the Percentage of Patients With a Negative Mycological Culture. |
12; 10 | <0.05 sig |
| SECONDARY Proximal Clearance of Fungus on Nail |
0.44; 0.15 | <0.05 sig |
Summary
The investigators would like to test the treatment of onychomycosis using a 0.65 millisecond pulsed 1064 nm laser fitted with a special onychomycosis handpiece. The investigators will compare the success rates of those receiving laser treatments with untreated patients. This study will provide a clinical basis for determining the relative effectiveness of an increasingly utilized treatment method.
Eligibility Criteria
Inclusion Criteria
- Have Onychomycosis on at least one toe.
- Age 18 or older.
- Consent to research use of their toenail clippings.
Exclusion Criteria
- Current immunosuppression (cancer, autoimmune disease) or taking immunosuppressive drugs.
- Pregnant female.
- Age 75 or older.
Data sourced from ClinicalTrials.gov (NCT01666002). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.